Logo for Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Investor Relations Material

Latest events

Logo for Rhythm Pharmaceuticals Inc

Q1 2025

Rhythm Pharmaceuticals
Logo for Rhythm Pharmaceuticals

Q1 2025

7 May, 2025
Logo for Rhythm Pharmaceuticals

Study Result

7 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Rhythm Pharmaceuticals Inc

Access all reports
Rhythm Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for rare genetic disorders related to obesity. The company’s primary area of focus is on conditions caused by impairments in the melanocortin-4 receptor (MC4R) pathway, which regulates hunger and body weight. Rhythm Pharmaceuticals aims to address unmet medical needs by developing targeted therapies that can help manage severe obesity and related symptoms in patients with specific genetic deficiencies. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.